Dyne Therapeutics Inc — 四半期キャッシュフロー (NASDAQ:DYN) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 691.23 M721.07 M728.99 M867.06 M1.19 B 負債合計 61.4 M52.1 M157.55 M175.28 M214.83 M 純資産合計 629.84 M668.97 M571.45 M691.78 M972.13 M 負債および純資産合計 691.23 M721.07 M728.99 M867.06 M1.19 B 有利子負債合計 ——116.08 M115.43 M169.2 M 純負債 ——-567.85 M-676.46 M-941.36 M

ニュース

Jefferies reiterates Buy on BioMarin stock after DMD trial data

Micron and Palantir among market cap stock movers on Tuesday

Dyne Therapeutics, Inc. (DYN) Presents at TD Cowen 46th Annual Health Care Conference Prepared Remarks Transcript

Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case (NASDAQ:DYN)

Baird、臨床試験の進展を受けてDyne Therapeutics株の投資判断を維持

Baird reiterates Dyne Therapeutics stock rating on trial progress

Jones Trading、DMDおよびDM1の最新情報を受けてDyne Therapeutics株の買い推奨を継続

Jones Trading reiterates Buy on Dyne Therapeutics stock after DMD, DM1 updates

Stifel、治験デザインを受けてDyne Therapeutics株の投資判断を据え置き

Stifel reiterates Dyne Therapeutics stock rating on trial design

筋ジストロフィーデータを受けてDyne株は一段と強含みとJones

Dyne stock looks stronger after muscular dystrophy data, says Jones